Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Disparities in the use of antenatal corticosteroids among women with hypertension in North Carolina

Abstract

Objective

To evaluate antenatal corticosteroids (ANS) use in pregnant women with hypertension.

Study design

Retrospective analysis of ANS use in the Perinatal Quality Collaborative of North Carolina between 2015 and 2017.

Results

Twenty-five centers participated, with 9% (1580/17,692) of mothers delivering at <34 weeks; of these, 81% (1286/1580) received a full course of ANS, which was not different between phases (p = 0.32), or between Level III/IV neonatal intensive care units (NICUs; 82%), and I/II NICUs (76%) (p = 0.05). In Level III/IV NICUs, White mothers were more likely to receive ANS (87%) than African Americans (77%) or other race/ethnicity (80%) (including Hispanics) (p = 0.001). ANS use did not differ among mothers with different payers (p = 0.94).

Conclusion

The rates of full ANS courses did not significantly increase from 2015–2017 and disparities persisted. Targeted efforts to improve ANS exposures among hypertensive African American and Hispanic mothers, as well as in community hospital settings are needed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2009 period linked birth/infant death data set. Natl Vital- Stat Rep. 2013;61:1–27.

    CAS  PubMed  Google Scholar 

  2. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126:443–56.

    Article  PubMed  Google Scholar 

  3. Hintz SR, Kendrick DE, Wilson-Costello DE, Das A, Bell EF, Vohr BR, et al. Early-childhood neurodevelopmental outcomes are not improving for infants born at <25 weeks’ gestational age. Pediatrics. 2011;127:62–70.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Younge N, Goldstein RF, Bann CM, Hintz SR, Patel RM, Smith PB, et al. Survival and neurodevelopmental outcomes among periviable infants. N Engl J Med. 2017;376:617–28.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA. 2015;314:1039–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.

  7. Carlo WA, McDonald SA, Fanaroff AA, Vohr BR, Stoll BJ, Ehrenkranz RA, et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks’ gestation. JAMA. 2011;306:2348–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD. National Institute of Child Health and Human Development Neonatal Research Network. Intensive care for extreme prematurity-moving beyond gestational age. N Engl J Med. 2008;358:1672–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Profit J, Goldstein BA, Tamaresis J, Kan P, Lee HC. Regional variation in antenatal corticosteroid use: a network-level quality improvement study. Pediatrics 2015;135:e397–404.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. The Joint Commission. Specifications manual for joint commission national quality measures (version 2018A) 2018. The Joint Commission web site. http://www.jointcommission.org/perinatal_care/. Accessed 17 Aug 2018.

  11. Razaz N, Skoll A, Fahey J, Allen VM, Joseph KS. Trends in optimal, suboptimal, and questionably appropriate receipt of antenatal corticosteroid prophylaxis. Obstet Gynecol. 2015;125:288–96.

    Article  PubMed  Google Scholar 

  12. Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ. Births: final data for 2013. Natl Vital- Stat Rep. 2015;64:1–68.

    PubMed  Google Scholar 

  13. Centers for Disease Control and Prevention (CDC). National vital statistics reports, Volume 64, Number 12. CDC web site. https://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_12.pdf. Accessed 8 Aug 2018.

  14. American College of Obstetricians and Gynecologists; Task Force on Hypertension in PregnancyHypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.

    Article  Google Scholar 

  15. [No authors listed]. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22.

  16. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2010;4:68–78.

    Article  CAS  PubMed  Google Scholar 

  17. Leviton LC, Goldenberg RL, Baker CS, Schwartz RM, Freda MC, Fish LJ, et al. Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial. JAMA. 1999;281:46–52.

    Article  CAS  PubMed  Google Scholar 

  18. Wirtschafter DD, Danielsen BH, Main EK, Korst LM, Gregory KD, Wertz A, et al. Promoting antenatal steroid use for fetal maturation: results from the California Perinatal Quality Care Collaborative. J Pediatr. 2006;148:606–12.

    Article  CAS  PubMed  Google Scholar 

  19. Lee HC, Lyndon A, Blumenfeld YJ, Dudley RA, Gould JB. Antenatal steroid administration for premature neonates in California. Obstet Gynecol. 2011;117:603–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Perinatal Quality Collaborative of North Carolina. Perinatal quality collaborative of North Carolina annual report of very low birth weight infants born in 2016. Burlington, VT: Vermont Oxford Network; 2018.

    Google Scholar 

  21. Walsh MC, Bell EF, Kandefer S, Saha S, Carlo WA, D’Angio CT, et al. Neonatal outcomes of moderately preterm infants compared to extremely preterm infants. Pediatr Res. 2017;82:297–304.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Smith PB, Ambalavanan N, Li L, Cotten CM, Laughon M, Walsh MC, et al. Approach to infants born at 22 to 24 weeks’ gestation: relationship to outcomes of more-mature infants. Pediatrics. 2012;129:e1508–16.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Leviton LC, Baker S, Hassol A, Goldenberg RL. An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids. Am J Obstet Gynecol. 1995;173:312–6.

    Article  CAS  PubMed  Google Scholar 

  24. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol. 2007;196:514 e1–9.

    Article  Google Scholar 

  25. Howell EA. Reducing disparities in severe maternal morbidity and mortality. Clin Obstet Gynecol. 2018;61:387–99.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Vermont Oxford Network played no role in the design, conduct, analysis, interpretation, or reporting. The views, conclusions, and opinions expressed are solely those of the authors and do not represent those of the Vermont Oxford Network.

Funding

NY received support from the National Institutes of Health (K12 HD043494-14).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Margarita Bidegain.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Puia-Dumitrescu, M., Greenberg, R.G., Younge, N. et al. Disparities in the use of antenatal corticosteroids among women with hypertension in North Carolina. J Perinatol 40, 456–462 (2020). https://doi.org/10.1038/s41372-019-0555-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-019-0555-y

Search

Quick links